# Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies

> **NCT05807659** · PHASE2 · UNKNOWN · sponsor: **Sichuan University** · enrollment: 18 (estimated)

## Conditions studied

- Myeloid Malignancies

## Interventions

- **DRUG:** fractionated busulfan-based conditioning regimen

## Key facts

- **NCT ID:** NCT05807659
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-16
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05807659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05807659, "Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05807659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*